Switching with Adalimumab Biosimilar Maintains Benefit for Plaque Psoriasis
Trial data support multiple switching between biosimilar and reference product over a 48-week course for the treatment of psoriasis.
Source: hcplive.com
Alan Menter News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alan Menter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alan Menter Today - Breaking & Trending Today
Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced positive top-line results from the DISCREET trial, a Phase 3, multicenter, randomized, placebo-controlled,...
Source: prnewswire.com